Share:
ResearchAndMarkets.com s offering.
The global precision aquaculture market is estimated to grow from USD 407 million in 2021 to USD 794 million by 2026; at a CAGR of 14.3%.
Precision aquaculture technology has the potential to transform the aquaculture industry, making traditional aquaculture activities more efficient and economical.
The growth of the precision aquaculture market is driven by factors such as growing investments in technological research and product innovation, the surging adoption of advanced technologies such as IoT, ROVs, and AI for the real-time monitoring of aquaculture farms, the rising demand for protein-rich aqua food, and increasing support by worldwide governments for infrastructure development in aquaculture.
/PRNewswire/ The "Global Precision Aquaculture Market with COVID-19 Impact Analysis by System Type (Feeding Systems, Monitoring & Control, Underwater ROVs),.
EMA Says Increase In Vaccine Manufacturing Capacity, Supply For COVID-19 Vaccines From Biontech/Pfizer & Moderna
Published: 04/23/2021 12:47 GMT
Moderna Inc (MRNA) - Ema Says Increase in Vaccine Manufacturing Capacity and Supply for Covid-19 Vaccines From Biontech/pfizer and Moderna.
Ema - Approved an Increase in Batch Size and Associated Process Scale Up at Pfizer’s Vaccine Manufacturing Site in Puurs, Belgium.
Ema Says Ema Has Approved an Increase in Batch Size and Associated Process Scale Up at Pfizer s Vaccine Manufacturing Site in Puurs, Belgium .
Ema Says Chmp Also Recommended Approval of a New Filling Line at Moderna s Finished Product Manufacturing Site for Eu in Rovi, Spain .
Not yet inoculated against misleading statements. (White House)
“When I came into office, the prior administration had contracted for not nearly enough vaccine to cover adults in America. We rectified that.”
During a March 2 news conference on the covid-19 pandemic, President Joe Biden claimed that former President Donald Trump’s administration did not ensure there would be enough vaccines for the American public.
“When I came into office, the prior administration had contracted for not nearly enough vaccine to cover adults in America,” said Biden. “We rectified that.”
Biden then announced he was using the Defense Production Act to facilitate a partnership between two competing drug companies: Merck had agreed to help manufacture the recently authorized Johnson & Johnson vaccine.
Biden s Criticism of Trump Team s Vaccine Contracts Is a Stretch medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.